Pharmacology, Toxicology and Pharmaceutical Science
Direct Oral Anticoagulant
100%
Blood Clotting Factor 10a Inhibitor
43%
Rivaroxaban
34%
Betrixaban
26%
Thrombin Inhibitor
25%
Apixaban
22%
Emergency
21%
Thrombin
13%
Andexanet Alfa
13%
Warfarin
13%
Atrial Fibrillation
12%
Low Molecular Weight Heparin
12%
Reagent
11%
Prospective Study
11%
Active Metabolite
11%
Recombinant Interleukin 2
11%
Venous Thromboembolism
11%
Therapeutic Drug Monitoring
11%
Viper Venom
10%
Heparin
10%
Drug
10%
Daboia russellii
9%
Thromboplastin
9%
Antivitamin K
8%
Dabigatran
7%
Bleeding
7%
Prothrombin
7%
Pharmacokinetics
6%
Heparin Lyase
5%
Medicine and Dentistry
Assay
39%
Direct Oral Anticoagulant
34%
Plasma
28%
Betrixaban
24%
Blood Clotting Factor 10a Inhibitor
20%
Inpatient
20%
Analysis
16%
Assessment
14%
Bleeding
14%
Apixaban
12%
Venous Thromboembolism
12%
Low Molecular Weight Heparin
12%
Combination Therapy
12%
Blood Stasis
11%
Thrombin
11%
Human
11%
Laboratory
11%
Thrombophilia
11%
Diagnostic Test
11%
Patient
11%
Mass Spectrum
11%
Therapeutic Drug Monitoring
11%
Dextran Sulfate
11%
Consensus
11%
Measurement
8%
Coagulation
6%
Heparin
5%
Heparin Lyase
5%
Biochemistry, Genetics and Molecular Biology
Thrombin
45%
Time
16%
Heparin
14%
Electric Potential
11%
Sample
11%
D-Dimer
11%
Mass Spectrometry
11%
Urine Sampling
11%
Taxonomy
11%
Thrombin
11%
Coagulation
10%
Partial Thromboplastin Time
7%
Viperinae
7%
Prothrombin Time
7%
Blood Level
5%
Clinical Study
5%
Liquid Chromatography Tandem Mass Spectrometry
5%
Anticoagulation
5%